Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-09-07
1997-06-03
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514255, 514912, A61K 3170, A61K 31495
Patent
active
056354860
ABSTRACT:
The present invention provides an ophthalmic composition comprising a sleep inducing substance or a sleep inhibiting substance, and the sleep inducing substance or the sleep inhibiting substance is derived from an organism. Thus, the invention provides an ophthalmic composition comprising a sleep adjusting substance which normalizes irregularity of the rhythm of sleep and a liquid ophthalmic medicament comprising the composition, the composition and the medicament being safe and obtainable by anyone, and a method for regulating the rhythm of sleep comprising instilling the ophthalmic medicament including the sleep adjusting substance to an individual.
REFERENCES:
H. Nishino, Zoku Baiorizumu to Sono Kiko, Kodansha Scientic, 1978, pp. 203-214, "Amatomical and Functional Communication Between Suprachiasmatic Nucleus and Other Center Sites".
A.A. Borbely et al, Physiological Reviews, vol. 69, No. 2, Apr. 1989, pp. 605-657, "Endogenous Sleep Promoting Substances and Sleep Reguration".
Arendt et al, British Medical Journal, vol. 292, p. 1170, May 1986, "Short Reports--Alleviation of Jet Lag by Melatonin: Preliminary Results of Controlled Double Blind Trial".
T. Miyata et al, Life Sciences, vol. 15, pp. 1135-1152, 1974, "Effects of Inbacerebral Administration of Piperidine on EEG and Behavior".
Y. Komoda et al, Chem. Pharm. Bull., 38(7) pp. 2057-2059, Jul. 1990, "SPS B, A Physiological Sleep Regulator, From the Brainstems of Sleep-Deprived Rats, Identified as Oxidized Glutathione".
G.A. Schoenenberger et al, Proc. Natl. Acad. Sci. USA, vol. 74, No. 3, pp. 1282-1286, Mar. 1977, "Characterization of a delta-electroence-phalogram(-sleep)-inducing peptide".
D. Schneider-Helmert et al, Experientia, vol. 37, pp. 913-917, "The Influence of Synthetic DSIP (delta-sleep-including-peptide) on disturbed human sleep". (1981).
K. Honda et al, Report of the Institute for Medical & Dental Engineering, vol. 18, pp. 93-95, 1984, "Little Sleep-Promoting Effects of Intra-ventricularly Infused Uracil in Unrestrained Rats".
H. Matsumura et al, Brain Research, pp. 1-8, 1987, "Awaking Effect of PGE.sub.2 Microinjected Into the Preoptic Area of Rats".
S. Inoue et al, Proc. Natl. Acad. Sci. USA, vol. 81, pp. 6240-6244, Oct. 1984, "Differential Sleep-Promoting Effects of Five Sleep Substances Nocturnally Infused in Unrestrained Rats".
J.M. Krueger et al, Am. J. Physiol., 246: R994-999, "Sleep Promoting Effects of Endogenous Pyrogen (Interleukin-1)".
R. Ueno et al, Advances in Prostaglandin, Thromboxane, and Leuko-triene Research, vol. 15, 1985, "Prostaglandin D.sub.2 : A Cerebral Sleep-Regulating Substance in Rats".
Y. Takahashi et al, Shinkei-Seishin-Yakuri (Japanese Phonetic), vol. 6, No. 4, pp. 235-239, "Toward Clinical Application of Endogenous Sleep-Promoting Factor", 1985.
K. Honda et al, Neuroscience Research, 1, (1984), pp. 243-252, "Uridine as an Active Component of Sleep-Promoting Substance; its Effects of Nocturnal Sleep in Rats".
O. Hayaishi, The Journal of Biological Chemistry, vol. 263, No. 29, Oct. 15, 1988, pp. 14593-14596, "Sleep-Wake Regulation by Prostaglandins D.sub.2 and E.sub.2 ".
M. Radulovacki et al, Phychopharmacology (1985) 87, pp. 136-140, "A Comparison of the Dose Response Effects of Pyrimidine Ribonucleosides and Adenosine on Sleep in Rats".
Hidaka Takayoshi
Yamamoto Kozo
Fay Zohreh
Kanegafuchi Kagaku Kogyo & Kabushiki Kaisha
LandOfFree
Ophthalmic composition comprising a sleep adjusting substance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ophthalmic composition comprising a sleep adjusting substance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic composition comprising a sleep adjusting substance will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-391713